1,7-phenanthroline has been researched along with mannosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraku, Y; Kawanishi, S | 1 |
| Farley, JR; Magnusson, P | 1 |
2 other study(ies) available for 1,7-phenanthroline and mannosamine
| Article | Year |
|---|---|
Involvement of oxidative DNA damage and apoptosis in antitumor actions of aminosugars.
Topics: Amino Sugars; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Survival; Copper; DNA Damage; DNA Fragmentation; Enzyme Inhibitors; Free Radical Scavengers; Galactosamine; Glucosamine; Hexosamines; Humans; Hydrogen Peroxide; Oxidation-Reduction; Phenanthrolines; Tumor Cells, Cultured | 1999 |
Effects of tunicamycin, mannosamine, and other inhibitors of glycoprotein processing on skeletal alkaline phosphatase in human osteoblast-like cells.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Apoptosis; Bone and Bones; Cell Proliferation; Dose-Response Relationship, Drug; Glycosylphosphatidylinositols; Hexosamines; Humans; Kinetics; Membrane Glycoproteins; Osteoblasts; Osteosarcoma; Phenanthrolines; Tumor Cells, Cultured; Tunicamycin | 2005 |